CAGGIA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 3.900
EU - Europa 2.400
AS - Asia 2.201
SA - Sud America 329
AF - Africa 62
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.901
Nazione #
US - Stati Uniti d'America 3.799
SG - Singapore 678
CN - Cina 566
DE - Germania 534
GB - Regno Unito 506
IT - Italia 506
VN - Vietnam 246
BR - Brasile 240
HK - Hong Kong 227
SE - Svezia 163
BD - Bangladesh 149
IE - Irlanda 137
FI - Finlandia 132
RU - Federazione Russa 129
FR - Francia 75
UA - Ucraina 72
IN - India 65
KR - Corea 59
CA - Canada 47
ID - Indonesia 40
TR - Turchia 39
AR - Argentina 34
MX - Messico 32
NL - Olanda 30
BG - Bulgaria 25
JP - Giappone 17
PL - Polonia 17
CO - Colombia 16
IQ - Iraq 14
ZA - Sudafrica 14
MA - Marocco 13
CL - Cile 12
ES - Italia 11
LT - Lituania 11
SA - Arabia Saudita 11
EC - Ecuador 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
AT - Austria 8
EG - Egitto 8
VE - Venezuela 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
PH - Filippine 7
PK - Pakistan 7
TH - Thailandia 7
MY - Malesia 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
HN - Honduras 5
IR - Iran 5
JO - Giordania 5
LB - Libano 4
NP - Nepal 4
RS - Serbia 4
SI - Slovenia 4
AU - Australia 3
BE - Belgio 3
BH - Bahrain 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
MK - Macedonia 3
PE - Perù 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BI - Burundi 1
BS - Bahamas 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
Totale 8.889
Città #
Ashburn 497
Singapore 428
Santa Clara 334
Southend 297
Hong Kong 221
Chandler 215
San Jose 210
Hefei 178
Fairfield 174
Woodbridge 164
Dublin 137
Munich 130
Houston 127
Beijing 116
Jacksonville 111
Dallas 109
Los Angeles 109
Nyköping 107
Dearborn 101
Helsinki 96
New York 93
Wilmington 86
Chicago 85
Ho Chi Minh City 85
Council Bluffs 74
Seattle 74
London 69
Cambridge 67
Seoul 59
Modena 55
Hanoi 49
The Dalles 41
Milan 39
Salt Lake City 37
Lauterbourg 33
Enfield 32
Fremont 32
Ann Arbor 31
Bologna 31
Rome 30
Jakarta 27
Shanghai 26
Buffalo 24
Princeton 23
Sofia 22
Orem 21
San Diego 21
São Paulo 20
Eugene 19
Tampa 19
Moscow 18
Phoenix 18
Bremen 15
Turku 15
Frankfurt am Main 14
Reggio Emilia 14
Atlanta 13
Chennai 13
Elk Grove Village 13
Falls Church 13
Izmir 13
Toronto 13
Columbus 12
Boardman 11
Da Nang 11
Des Moines 11
Guangzhou 11
Mexico City 11
Parma 11
Stockholm 11
Tokyo 11
Denver 10
Istanbul 10
Lancaster 10
Nairobi 10
Nanjing 10
Redondo Beach 10
Dong Ket 9
Johannesburg 9
Kent 9
Poplar 9
Redwood City 9
San Francisco 9
Warsaw 9
Dhaka 8
Haiphong 8
Manchester 8
Baghdad 7
Brooklyn 7
Miami 7
Montreal 7
Newark 7
Nuremberg 7
Ottawa 7
Querétaro 7
Amsterdam 6
Brasília 6
Cardiff 6
Haarlem 6
Hải Dương 6
Totale 5.690
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 584
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 486
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 403
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 399
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 375
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 368
Quality of life and anxious-depressive symptoms in cancer patients undergoing mindfulness-based interventions: Feasibility and preliminary outcomes on prospective single-centre case-control study (MIND4ME St.) 354
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 348
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 329
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 325
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 312
Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer. 311
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 309
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 309
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 303
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 295
Gene expression profile of the hippocampus of a behavioural model of depression 292
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 291
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 283
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 270
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 269
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 257
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 257
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 229
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 215
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 169
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 165
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 162
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 154
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 62
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 36
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 35
Totale 8.956
Categoria #
all - tutte 31.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 18 47 14 25 18 29 15 10 38 43 75 55
2022/2023759 66 92 46 71 48 69 12 57 170 9 85 34
2023/2024489 19 23 33 70 72 49 55 50 11 17 33 57
2024/20251.643 39 22 40 101 265 226 181 118 184 104 143 220
2025/20263.602 256 139 298 408 641 223 384 160 300 336 243 214
2026/202797 97 0 0 0 0 0 0 0 0 0 0 0
Totale 8.956